Psoriasis: Biologics bring potential for long-term remission off treatment
GENEVA – The results of an extension study of two pivotal secukinumab studies point to a previously…
mdedge.com
TNF inhibitors associated with fewer side effects than methotrexate in children with psoriasis
An international study provides some needed data on the use of systemic treatments and their toxicities in…
mdedge.com
Ixekizumab found superior to ustekinumab in psoriasis at 24 weeks
ORLANDO – At 24 weeks, the IL-17A blocker ixekizumab was superior to the IL-12/IL-23 blocker…
mdedge.com
Jak Inhibition May Ameliorate Pruritus
Last week we reported the results of a metanalysis published in the Journal of Investigative Dermatology showing that certain agents are more effective in…
rheumnow.com